Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06487247 · ClinicalTrials.gov registry record · NA
HEME Home Transfusion Program
A NA study of Lymphoma and Leukemia, sponsored by Dana-Farber Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 700
- Enrollment target
- 2
- Study locations
NCT06487247 is a NA study of Lymphoma and Leukemia that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 700 participants, above the 481-participant average among 299 other Lymphoma trials with a reported enrollment target (46% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT06487247, a NA study of Lymphoma and Leukemia, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 700 participants
- Enrollment target
- 2
- Study locations
Study Summary
This research study is evaluating whether a new care delivery program that provides access to home blood transfusions in hospice (i.e, HEME-Hospice) compared to regular standard of care improves quality of life, mood, and end-of-life health care utilization for patients with hematologic malignancies.
Conditions Studied
Interventions
- BEHAVIORAL HEME-Hospice Program
Study Locations (2)
Massachusetts
- Brigham and Women's Hospital - Boston
- Dana-Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2025-09-10 |
| Est. Completion | 2029-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06487247
The ClinicalTrials.gov registry entry for NCT06487247 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 481-participant average among 299 other Lymphoma trials with a reported enrollment target (46% higher). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Lymphoma appearing as the primary indexed condition, and to 1 intervention - of which HEME-Hospice Program is the first listed.
NCT06487247 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06487247 about?
NCT06487247 is a clinical study titled "HEME Home Transfusion Program". This research study is evaluating whether a new care delivery program that provides access to home blood transfusions in hospice (i.e, HEME-Hospice) compared to regular standard of care improves quality of life, mood, and end-of-life health care utilization for patients with hematologic malignancies...
What is the current status of trial NCT06487247?
This trial is currently recruiting. It is a NA study. The enrollment target is 700 participants. The study started on 2025-09-10. Estimated completion is 2029-05-31.
What conditions does trial NCT06487247 study?
This clinical trial studies the following conditions: Lymphoma, Leukemia, Myelodysplastic Syndromes, Hematologic Malignancy, Myeloma.
What interventions are being tested in trial NCT06487247?
The interventions under investigation include: HEME-Hospice Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06487247?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06487247 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
RECRUITING · NA
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
RECRUITING · NA
-
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
RECRUITING · NA
-
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.